SCHEDULE: FMR LLC Discloses 0.0% Stake in Cargo Therapeutics
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson reported a 0.0% beneficial ownership stake in Cargo Therapeutics Inc. common stock as of July 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson filed an Amendment No. 4 to Schedule 13G regarding their beneficial ownership of Common Stock in CARGO THERAPEUTICS INC.
- As of July 31, 2025, FMR LLC and Abigail P. Johnson beneficially own an aggregate of 7,196 shares of CARGO THERAPEUTICS INC. Common Stock.
- This aggregate amount represents 0.0% of the class of securities.
- FMR LLC holds sole voting power over 950 shares and sole dispositive power over 7,196 shares.
- Abigail P. Johnson holds sole dispositive power over 7,196 shares, with no sole or shared voting power.
- The filing was made pursuant to Rule 13d-1(b).
- Abigail P. Johnson is identified as a Director, Chairman, and Chief Executive Officer of FMR LLC, and a predominant owner of Series B voting common shares of FMR LLC (49% voting power).
Sentiment
Score: 5
Explanation: This is a factual disclosure of beneficial ownership, not a performance report, and therefore carries a neutral sentiment.
Positives
- NA This filing is a routine disclosure of beneficial ownership and does not contain information typically categorized as positives regarding company performance or outlook.
Negatives
- NA This filing is a routine disclosure of beneficial ownership and does not contain information typically categorized as negatives regarding company performance or outlook.
Risks
- NA This filing is a routine disclosure of beneficial ownership and does not detail company-specific risks beyond the ownership structure itself.
Future Outlook
NA This filing is a Schedule 13G, which reports beneficial ownership and does not provide forward-looking statements or guidance.
Industry Context
NA This filing is a routine disclosure of beneficial ownership by an institutional investor and does not provide analysis of broader industry trends or competitors.
Stakeholder Impact
- Primarily impacts shareholders by providing transparency regarding significant institutional ownership, though the reported stake is 0.0%.
Key Dates
| Date | Description |
|---|---|
| 05/23/2023 | Effective date of Power of Attorney for Richard Bourgelas to sign on behalf of FMR LLC and Abigail P. Johnson. |
| 07/31/2025 | Date of event which requires filing of this statement (beneficial ownership snapshot date). |
| 08/06/2025 | Date of filing of this Schedule 13G. |
Keywords
CARGO THERAPEUTICS INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.